G4 on the NRP1 promoter could be a potentially valuable biomarker for predicting COVID-19 complications, and targeting G4 on the NRP1 promoter may yield favorable clinical outcomes in COVID-19 patients. The gene discussed is NRP1; the disease is COVID-19.